EyePoint (EYPT) Property, Plant & Equipment (Net) Growth (5y) (2016 - 2026)
EyePoint (EYPT) Property, Plant & Equipment (Net) Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | EyePoint | 1.07 Mn | -221.48 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.16% |
| Dec 31, 2025 | 70.30% |
| Sep 30, 2025 | 78.28% |
| Jun 30, 2025 | 84.31% |
| Mar 31, 2025 | 80.06% |
| Dec 31, 2024 | 87.06% |
| Sep 30, 2024 | 85.12% |
| Jun 30, 2024 | 75.28% |
| Mar 31, 2024 | 73.48% |
| Dec 31, 2023 | 78.72% |
| Sep 30, 2023 | 69.52% |
| Jun 30, 2023 | 62.57% |
| Mar 31, 2023 | 59.85% |
| Dec 31, 2022 | 35.94% |
| Sep 30, 2022 | 24.67% |
| Jun 30, 2022 | 28.84% |
| Mar 31, 2022 | 17.73% |
| Dec 31, 2021 | 15.56% |
| Sep 30, 2021 | 16.86% |
| Jun 30, 2021 | 12.17% |